Oxazolidinones, dihydrofuranones, and pyrrolidinones as inactivators and substrates of monoamine oxidase B: approaches to the design of antiparkinsonian agents.
Silverman
R B
RB
Department of Chemistry, Northwestern University, Evanston, Illinois 60208-3113, USA.
D000978:Antiparkinson Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology; D010080:Oxazoles / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D011760:Pyrrolidinones / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology
D000978:Antiparkinson Agents; D008996:Monoamine Oxidase Inhibitors; D010080:Oxazoles; D011760:Pyrrolidinones; C064210:oxazolidine